X-Inactivation
Solvents
Capillary Beds
Titration in Nonaqueous Solvents
Activation and Inactivation of G Proteins
What are Viruses?
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 28, 2026

A Scalable Balz-Schiemann Reaction Protocol in a Continuous Flow Reactor
Published on: February 10, 2023
Duarte L Martins1,2, Jure Sencar1,2, Nikolaus Hammerschmidt1,2
1Austria Centre for Industrial Biotechnology, Vienna, Austria.
Continuous virus inactivation (VI) is now achievable in biopharma manufacturing using a novel reactor. This system ensures effective viral clearance with a narrow residence time distribution, matching batch process results.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: